1315 Capital

What is 1315 Capital?

1315 Capital is a private investment firm that specializes in providing expansion and growth capital to commercial-stage healthcare companies with a focus on healthcare services, medical technology, medtech & pharma outsourcing, health & wellness.

Established in 2014 and headquartered in Philadelphia, Pennsylvania, the firm manages over $1 billion with an investment philosophy that emphasizes partnering with strong management teams to scale platform companies into large and influential businesses that have a positive impact on patients, physicians, and the healthcare system at large.

1315 Capital aims to engage deeply with the firms in their portfolio through a distinctive Operating Team model which aids in due diligence, drives decision-making, and contributes to the pursuit of premium exits.

They utilize a vast network to source deals, attract management talent, fill advisory roles, and secure board positions.

The investor showcases a diverse portfolio including global medical simulation and education products manufacturers, AI-enabled decision support technology for life sciences, hydrophilic coatings for medical devices, cost-containment services for hospital equipment liquidation, as well as companies in cosmeceuticals, remote EEG monitoring, dermatology, oncology diagnostics, transcranial magnetic stimulation, healthcare benefits, and more.

Their commitments are characterized by significant involvement, with investments that range up to $19 million per deal.

The firm is invested in areas including Software, BioTech, Business Solutions, FinTech & Financial Services, Hardware & Manufacturing, CleanTech, A.I. & Big Data, HealthTech & Fitness, Medical Devices & Hospital Services, Life Science, and Oncology.

What they say:

We invest in commercial stage pharmaceuticals, medical technologies, and healthcare services, providing expansion and growth capital.